Sridhar Kosaraju
Director/Board Member bij 10X GENOMICS, INC.
Vermogen: 2 M $ op 31-03-2024
Profiel
Momenteel is Sridhar Kosaraju Chief Executive Officer & Director bij Inscripta, Inc. Hij zit ook in de raad van bestuur van 10X Genomics, Inc. In het verleden bekleedde de heer Kosaraju de functie van President van Penumbra, Inc. en Managing Director-Equity Capital Markets bij JPMorgan Securities LLC. Sridhar Kosaraju behaalde een bachelorgraad aan het Massachusetts Institute of Technology.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
10X GENOMICS INC CLASS A
0.03% | 14-06-2023 | 35 443 ( 0.03% ) | 1 M $ | 31-03-2024 |
NEVRO CORP.
0.05% | 31-03-2024 | 18 486 ( 0.05% ) | 266 938 $ | 31-03-2024 |
Actieve functies van Sridhar Kosaraju
| Bedrijven | Functie | Begin |
|---|---|---|
| 10X GENOMICS, INC. | Director/Board Member | 01-03-2019 |
| NEVRO CORP. | Director/Board Member | 31-08-2021 |
Inscripta, Inc.
 Inscripta, Inc. Miscellaneous Commercial ServicesCommercial Services Inscripta, Inc. engages in the provision of precision genome engineering solutions. Its technology includes onyx platform, the MAD7 nuclease, and biosecurity. The company was founded by Ryan T. Gill, Andrew Garst, and Tanya Lipscomb and is headquartered in Boulder, CO. | Chief Executive Officer | 27-10-2020 |
| Testing For America | Director/Board Member | - |
Eerdere bekende functies van Sridhar Kosaraju
| Bedrijven | Functie | Einde |
|---|---|---|
| PENUMBRA, INC. | Director of Finance/CFO | 01-11-2019 |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Corporate Officer/Principal | 01-05-2015 |
Opleiding van Sridhar Kosaraju
| Massachusetts Institute of Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| PENUMBRA, INC. | Health Technology |
| 10X GENOMICS, INC. | Health Technology |
| NEVRO CORP. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |
Inscripta, Inc.
Inscripta, Inc. Miscellaneous Commercial ServicesCommercial Services Inscripta, Inc. engages in the provision of precision genome engineering solutions. Its technology includes onyx platform, the MAD7 nuclease, and biosecurity. The company was founded by Ryan T. Gill, Andrew Garst, and Tanya Lipscomb and is headquartered in Boulder, CO. | Commercial Services |
| Testing For America |
